187 related articles for article (PubMed ID: 34722340)
1. Donor-Derived Human Parvovirus B19 Infection in Kidney Transplantation.
Yu Y; Wei C; Lyu J; Wu X; Wang R; Huang H; Wu J; Chen J; Peng W
Front Cell Infect Microbiol; 2021; 11():753970. PubMed ID: 34722340
[TBL] [Abstract][Full Text] [Related]
2. Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia.
Plentz A; Würdinger M; Kudlich M; Modrow S
J Clin Virol; 2013 Oct; 58(2):443-8. PubMed ID: 23916377
[TBL] [Abstract][Full Text] [Related]
3. Clinical and immune features of human parvovirus B19 infection in allogeneic stem cell transplantation recipients: A retrospective monocentric study.
Sammut R; Feghoul L; Xhaard A; Dhedin N; Robin M; Michonneau D; Loschi M; Legoff J; de Peffault de Latour R; de Sicre de Fontbrune F
Transpl Infect Dis; 2023 Oct; 25(5):e14118. PubMed ID: 37594199
[TBL] [Abstract][Full Text] [Related]
4. Parvovirus B19 infection in kidney transplant recipients: A prospective study in a teaching hospital in Shanghai, China.
Huang Q; Wang Y; Chen R; Zhao Y; Wang H; Ma X; Li D; Liu Q; Chen X; He L; Zhang M; Li M
Transpl Immunol; 2022 Oct; 74():101667. PubMed ID: 35835294
[TBL] [Abstract][Full Text] [Related]
5. Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation.
Porignaux R; Vuiblet V; Barbe C; Nguyen Y; Lavaud S; Toupance O; Andréoletti L; Rieu P; Lévêque N
J Med Virol; 2013 Jun; 85(6):1115-21. PubMed ID: 23588740
[TBL] [Abstract][Full Text] [Related]
6. Look-back study on recipients of Parvovirus B19 (B19V) DNA-positive blood components.
Juhl D; Özdemir M; Dreier J; Görg S; Hennig H
Vox Sang; 2015 Nov; 109(4):305-11. PubMed ID: 26053938
[TBL] [Abstract][Full Text] [Related]
7. Low human parvovirus B19 (B19V) DNA prevalence in blood donors from Central-West Brazil.
Slavov SN; Gonçalves de Noronha LA; Gonzaga FAC; Pimentel BMS; Kashima S; Haddad R
J Med Microbiol; 2019 Apr; 68(4):622-626. PubMed ID: 30843782
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples.
Yu MY; Alter HJ; Virata-Theimer ML; Geng Y; Ma L; Schechterly CA; Colvin CA; Luban NL
Transfusion; 2010 Aug; 50(8):1712-21. PubMed ID: 20158689
[TBL] [Abstract][Full Text] [Related]
9. Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors.
Juhl D; Görg S; Hennig H
Vox Sang; 2014 Oct; 107(3):226-32. PubMed ID: 24916600
[TBL] [Abstract][Full Text] [Related]
10. Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation - Single-center experience and review.
Holterhus M; Hennies M; Hillmann H; Thorer H; Rossig C; Burkhardt B; Groll AH
Transpl Infect Dis; 2023 Apr; 25(2):e14028. PubMed ID: 36748962
[TBL] [Abstract][Full Text] [Related]
11. The Chemokine CXCL-10 Is a Marker of Infection Stage in Individuals With DNAemia Due to Parvovirus B19.
Weseslindtner L; Aberle JH; Hedman L; Hedman K
J Infect Dis; 2017 Jan; 215(2):214-220. PubMed ID: 27789725
[TBL] [Abstract][Full Text] [Related]
12. Parvovirus B19 DNAemia in pregnant women in relation to perinatal death: A nested case-control study within a large population-based pregnancy cohort.
Barlinn R; Trogstad L; Rollag H; Frøen F; Magnus P; Dudman SG
Acta Obstet Gynecol Scand; 2020 Jul; 99(7):856-864. PubMed ID: 31925774
[TBL] [Abstract][Full Text] [Related]
13. Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil.
Slavov SN; Rodrigues ES; Sauvage V; Caro V; Diefenbach CF; Zimmermann AM; Covas DT; Laperche S; Kashima S
J Med Virol; 2019 Jul; 91(7):1224-1231. PubMed ID: 30851123
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
15. Parvovirus B19 DNA detectable in hearts of patients with dilated cardiomyopathy, but absent or inactive in blood.
Russcher A; Verdonschot J; Molenaar-de Backer MWA; Heymans SRB; Kroes ACM; Zaaijer HL
ESC Heart Fail; 2021 Aug; 8(4):2723-2730. PubMed ID: 33931945
[TBL] [Abstract][Full Text] [Related]
16. Parvovirus B19 status in liver, kidney and pancreas transplant candidates: A single center experience.
Simunov B; Mrzljak A; Jurekovic Z; Zidovec Lepej S; Bainrauch A; Pavicic Saric J; Hruskar Z; Radmanic L; Vilibic-Cavlek T
World J Transplant; 2022 Nov; 12(11):378-387. PubMed ID: 36437842
[TBL] [Abstract][Full Text] [Related]
17. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.
Sakata H; Matsubayashi K; Ihara H; Sato S; Kato T; Wakisaka A; Tadokoro K; Yu MY; Baylis SA; Ikeda H; Takamoto S
Transfusion; 2013 Oct; 53(10 Pt 2):2556-66. PubMed ID: 23145866
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of intrauterine parvovirus B19 infection at birth - Value of DNA detection in neonatal blood and dried blood spots.
Russcher A; Enders A; de Brouwer CS; Oepkes D; Hahn R; Enders M; Kroes ACM; Vossen ACTM
J Clin Virol; 2020 Aug; 129():104482. PubMed ID: 32559661
[TBL] [Abstract][Full Text] [Related]
19. Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors.
Lee TH; Kleinman SH; Wen L; Montalvo L; Todd DS; Wright DJ; Tobler LH; Busch MP;
Transfusion; 2011 Sep; 51(9):1896-908. PubMed ID: 21303368
[TBL] [Abstract][Full Text] [Related]
20. A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion.
Kleinman SH; Glynn SA; Lee TH; Tobler LH; Schlumpf KS; Todd DS; Qiao H; Yu MY; Busch MP;
Blood; 2009 Oct; 114(17):3677-83. PubMed ID: 19687508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
